Literature DB >> 26878819

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary.

Richard R Orlandi1, Todd T Kingdom2, Peter H Hwang3.   

Abstract

BACKGROUND: The body of knowledge regarding rhinosinusitis (RS) continues to expand, with rapid growth in number of publications yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS). This executive summary consolidates the findings of the ICAR:RS document.
METHODS: ICAR:RS presents over 140 topics in the forms of evidence-based reviews with recommendations (EBRRs) and evidence-based reviews (EBR). The structured recommendations of the EBRR sections are summarized in this executive summary.
RESULTS: This summary compiles the EBRRs regarding medical and surgical management of acute RS (ARS) and chronic RS with and without nasal polyps (CRSwNP and CRSsNP).
CONCLUSION: This ICAR:RS Executive Summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.
© 2016 ARS-AAOA, LLC.

Entities:  

Keywords:  acute rhinosinusitis; chronic rhinosinusitis; endoscopic sinus surgery; evidence-based medicine; recurrent acute rhinosinusitis; rhinosinusitis; systematic review

Mesh:

Year:  2016        PMID: 26878819     DOI: 10.1002/alr.21694

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  25 in total

Review 1.  A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.

Authors:  W Colby Brown; Brent Senior
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-22       Impact factor: 4.806

2.  Fungal extracts stimulate solitary chemosensory cell expansion in noninvasive fungal rhinosinusitis.

Authors:  Neil N Patel; Vasiliki Triantafillou; Ivy W Maina; Alan D Workman; Charles C L Tong; Edward C Kuan; Peter Papagiannopoulos; John V Bosso; Nithin D Adappa; James N Palmer; Michael A Kohanski; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2019-03-20       Impact factor: 3.858

3.  Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.

Authors:  Auddie M Sweis; Tran B Locke; Kevin I Ig-Izevbekhai; Theodore C Lin; Ankur Kumar; Jennifer E Douglas; Andrew M Corr; Alyssa M Civantos; Siddhant H Tripathi; David W Kennedy; Michael A Kohanski; James N Palmer; Nithin D Adappa; John V Bosso
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

4.  Efficacy and safety of delivery of topical medication on to the frontal sinus at different head positions after frontal sinusotomy.

Authors:  Yu-Xiao Wu; Min Wang; Hui Li; Zhi-Min Xing; Mu-Han Shi; Shi-En Huang; Yan Liu; Cong-Li Geng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-13       Impact factor: 2.503

5.  CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis.

Authors:  Samuel D Racette; Alexander L Schneider; Meera Ganesh; Julia H Huang; David S Lehmann; Caroline P E Price; Samuel G Rodegherio; Abhita T Reddy; Jacob G Eide; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2022-04-01       Impact factor: 5.426

Review 6.  Medical interventions for chronic rhinosinusitis in cystic fibrosis.

Authors:  Tulasi Kota Karanth; Veena Kota Laxminarayan Kl Karanth; Bryan K Ward; Bradford A Woodworth; Laxminarayan Karanth
Journal:  Cochrane Database Syst Rev       Date:  2022-04-07

7.  Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps.

Authors:  Neil N Patel; Michael A Kohanski; Ivy W Maina; Vasiliki Triantafillou; Alan D Workman; Charles C L Tong; Edward C Kuan; John V Bosso; Nithin D Adappa; James N Palmer; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2018-05-09       Impact factor: 3.858

Review 8.  Medical interventions for chronic rhinosinusitis in cystic fibrosis.

Authors:  Tulasi Kota Karanth; Veena Kota Laxminarayan Kl Karanth; Bryan K Ward; Bradford A Woodworth; Laxminarayan Karanth
Journal:  Cochrane Database Syst Rev       Date:  2019-10-23

Review 9.  Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

10.  Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting.

Authors:  Mariel R Benjamin; Whitney W Stevens; Newton Li; Sumit Bose; Leslie C Grammer; Robert C Kern; Bruce K Tan; David B Conley; Stephanie S Smith; Kevin C Welch; Robert P Schleimer; Anju T Peters
Journal:  J Allergy Clin Immunol Pract       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.